Literature DB >> 4681870

Controlled trial comparing agar, intermittent phototherapy, and continuous phototherapy for reducing neonatal hyperbilirubinemia.

H M Maurer, C N Shumway, D A Draper, A A Hossaini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4681870     DOI： 10.1016/s0022-3476(73)80014-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

Review 1.  Use of phototherapy for neonatal hyperbilirubinemia. Fetus and Newborn Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1986-06-01       Impact factor: 8.262

2.  Agar in the management of hyperbilirubinaemia in the premature baby.

Authors:  C Romagnoli; G Polidori; M Foschini; L Cataldi; P De Turris; G Tortorolo; R Mastrangelo
Journal:  Arch Dis Child       Date:  1975-03       Impact factor: 3.791

3.  Phototherapy--a modified approach.

Authors:  Y C Govil; P K Misra; G K Malik; R Kaul
Journal:  Indian J Pediatr       Date:  1984 Jan-Feb       Impact factor: 1.967

4.  Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice.

Authors:  S P Lau; K P Fung
Journal:  Arch Dis Child       Date:  1984-09       Impact factor: 3.791

5.  Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants.

Authors:  Wen-Chieh Yang; Lu-Lu Zhao; Yu-Cheng Li; Chi-Hua Chen; Yu-Jun Chang; Yun-Ching Fu; Han-Ping Wu
Journal:  BMC Pediatr       Date:  2013-09-21       Impact factor: 2.125

6.  Comparison of efficacy, safety & satisfaction of intermittent versus continuous phototherapy in hyperbilirubinaemic newborns ≥35 week gestation: A randomized controlled trial.

Authors:  Sasi Bhushan Gottimukkala; Giridhar Sethuraman; Srinivasan Kitchanan; Surajit Pathak
Journal:  Indian J Med Res       Date:  2021-04       Impact factor: 2.375
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.